ID
45931
Beskrivning
Principal Investigator: Raymond J. Cho, MD, PhD, University of California, San Francisco, CA, USA MeSH: Xeroderma Pigmentosum, Complementation Group C,Carcinoma, Squamous Cell,Skin Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000830 Base mutations occur at higher frequencies within heterochromatin and late-replicating DNA. In this study, we show that regional differences in mutation frequency are absent in portions of the genome that are not transcribed within cutaneous squamous cell carcinomas (cSCCs) with an XPC-\- genetic background. The XPC-\- genetic background predicates a loss of global genome nucleotide excision repair (GG-NER), thus our data shows that regional differences in mutation frequency are a result of differential access of DNA repair protein. Unexpectedly, we also note that greater transcription reduces mutations on both strands of genes in heterochromatin, and only to those levels observed in euchromatin, in a XPC-dependent fashion. Therefore, transcription likely reduces mutation prevalence by increasing access to DNA repair proteins. This tripartite relationship between DNA repair, transcription, and chromatin state shows a new cancer risk factor in human populations.
Länk
Nyckelord
Versioner (1)
- 2024-03-09 2024-03-09 - Madita Rudolph
Rättsinnehavare
Raymond J. Cho, MD, PhD, University of California, San Francisco, CA, USA
Uppladdad den
9 mars 2024
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000830 XPC and Non-XPC Cutaneous Squamous Cell Carcinoma Mutation Rate Study
Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, gender, and germline repair genotype of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Sample ID, body site, analyte type, tumor status, histological type, primary or metastatic tumor, primary tumor location, and sequencing center of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
Similar models
Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- StudyEvent: SEV1
- Subject ID, consent group, subject source, and source subject ID of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, sample ID, sample source, source sample ID, and sample use variable of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Subject ID, gender, and germline repair genotype of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
- Sample ID, body site, analyte type, tumor status, histological type, primary or metastatic tumor, primary tumor location, and sequencing center of participants with or without cutaneous squamous cell carcinoma and involved in the "Xeroderma Pigmentosum, Complementation Group C, (XPC) and Non-XPC Cutaneous Squamous Cell Carcinoma (cSCC) Mutation Rate Study" project.
C0441833 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])